NASDAQ:VKTX

Viking Therapeutics Stock Predictions

etoro logo Buy VKTX
*Your capital is at risk
$29.33
+0.0400 (+0.137%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

VKTX Prediction Chart

VKTX Predictions History

Latest community submissions for VKTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sep 2, 2025 $26.06 -3.66% $27.49 X 94.80% 0
Sep 2, 2025 $26.43 -2.29% $27.49 X 96.15% 0
Sep 2, 2025 $49.00 +81.15% $27.49 V 21.75% 1
Sep 2, 2025 $46.00 +66.79% $27.49 X 32.67% 1
Aug 29, 2025 $26.55 -3.72% $27.05 V 98.17% 1
Aug 29, 2025 $26.94 -2.33% $27.05 V 99.59% 5
Aug 29, 2025 $45.00 +63.16% $27.05 X 33.64% 0
Aug 29, 2025 Bullish $27.05 V 0
Aug 29, 2025 $45.00 +69.05% $27.05 V 33.64% 0
Aug 28, 2025 $25.56 -3.99% $27.58 X 92.67% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for VKTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT VIKING THERAPEUTICS
Viking Therapeutics
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE